Biogen Idec Inc (BIIB) news: Biogen Idec's CEO Presents at Cowen & Company ... Seeking Alpha We have Daclizumab HYP that we hope that we will get a readout for in a Phase III trial later this year. We have it listed here but we don't really know how the data will shape up, so take that one with a little bit of a grain of salt. But we hope that ... |
